Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium
· Delayed Price · Currency is EUR
5.60
+0.42 (8.11%)
Nov 21, 2024, 11:58 AM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €145.04 million as of November 21, 2024. Its market cap has decreased by -57.71% in one year.
Market Cap
145.04M
Enterprise Value
118.97M
Revenue
6.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.60
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 145.04M, a decrease of -40.73%. That is a compound annual growth rate of -11.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 112.00M | -68.63% |
Dec 29, 2023 | 357.00M | 14.84% |
Dec 30, 2022 | 310.88M | -30.44% |
Dec 31, 2021 | 446.90M | 82.11% |
Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 32.13B |
UCB SA | 31.18B |
Financière de Tubize SA | 5.70B |
Fagron NV | 1.32B |
Ion Beam Applications SA | 363.60M |
Onward Medical N.V. | 166.22M |
Sequana Medical NV | 38.22M |